News
World Pancreatic Cancer Day
21. 11. 2024
Today we commemorate World Pancreatic Cancer Day, one of the most insidious types of cancer with a low chance of cure if not detected early. This disease often occurs without significant symptoms until advanced stages, which significantly reduces the possibilities of treatment and worsens the prognosis of patients.
We attended the IMSC 2024 conference
The International Mass Spectrometry Conference (IMSC)
The International Mass Spectrometry Conference (IMSC) is a world-renowned conference where news and modern trends in the field of mass spectrometry are presented. This conference is held regularly every 2 years and the 25th edition took place in the second half of August in Melbourne, Australia.
Approval of a clinical study for the early detection of pancreatic cancer
The State Institute for Drug Control (SÚKL) approved the clinical performance study of in vitro diagnostic device Lipidica
At the end of July, a study entitled “Clinical performance of medical device software Lipidica for processing data generated by lipidomic analysis in pancreatic cancer screening” was approved (protocol number: Lipidica_01-2024, version 1.0). The study is registered in the database ClinicalTrials.gov.
Lipidica builds on the results of ground-breaking research from the ERC CZ grant
ERC Scientific Mini-conference 13.6.2024, CEITEC, Brno
Co-founder of the spin-off company Lipidica, a.s. and currently ERC Advanced grant holder, prof. Michal Holčapek from the University of Pardubice presented his project focused on new dysregulations of lipids and the complexity of the mechanism of metabolic changes that cause these dysregulations. The conference was held with the participation of the president of the European Research Council (ERC), Maria Leptin and 12 holders of prestigious ERC grants from the Czech Republic.
We participated in an international comparison of laboratories
International Lipidomics Society
At the beginning of 2024, we joined a project organized by the International Lipidomic Society, which aims to harmonize concentrations for selected lipids in human plasma. This study should help to define the correct procedures in quantitative lipidomic analysis and at the same time reveal pitfalls and shortcomings of individual methods.
LIPIDICA AT ANALYTICA 2024 IN MUNICH
Presentation of research on the use of lipidomic analysis for the early detection of pancreatic cancer
The conference took place in the second week of April in Munich and is traditionally part of the leading world trade fair Analytica 2024, where the latest trends in laboratory technology, biotechnology and analytical chemistry are presented. This year, the fair was attended by 1,066 exhibitors and 34,000 visitors from all over the world.
PF 2024
We wish our partners and colleagues pleasant Christmas holiday and many personal and professional successes in the new year.
NEURON PRIZE 2023
NEURON PRIZE FOR CONNECTING SCIENCE AND BUSINESS
We are thrilled to announce that the prestigious Czech NEURON Prize for Connecting Science and Business was awarded to representatives of Lipidica a.s.